Our Kick-Off meeting for ELMUMY Horizon Cancer Mission research programme was held on February 8th, 2023. ELMUMY aims at yielding clinically actionable molecular features that could improve patient management of multiple myeloma. Mosaiques applies its validated CE-MS technology and contributes with biomarkers to predict progression of multiple myeloma.



LINK: www.elmumy.eu